Rubric Capital Management (New York)’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $31.5M | Buy |
|
|||||
|
2025
Q2 | $16.8M | Buy |
|
|||||
|
2025
Q1 | $3.79M | Hold |
|
|||||
|
2024
Q4 | $3.13M | Hold |
|
|||||
|
2024
Q3 | $3.38M | Sell |
|
|||||
|
2024
Q2 | $38.4M | Sell |
|
|||||
|
2024
Q1 | $66.3M | Sell |
|
|||||
|
2023
Q4 | $62M | Buy |
|
|||||
|
2023
Q3 | $49.2M | Hold |
|
|||||
|
2023
Q2 | $45.6M | Buy |
|
|||||
|
2023
Q1 | $25.7M | Buy |
|
|||||
|
2022
Q4 | $15.1M | Buy |
|
|||||
|
2022
Q3 | $9.23M | Buy |
|
|||||
|
2022
Q2 | $2.45M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $14.2M | Buy |
|